Supreme Court justices on Wednesday will hear arguments in a patent case that could change the way generic drug companies ...
WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed on Friday to hear a patent dispute involving Amarin Pharma's (AMRN.O), opens new tab cardiovascular drug Vascepa that could have broad ...
MedPage Today on MSN
SCOTUS Grapples With Marketing of Vascepa Generic With 'Skinny Label'
Can a generic manufacturer compare its product to the branded competitor?
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results